VANGUARD GROUP INC 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 5:43 pm Sale | 2026-03-13 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | VANGUARD GROUP INC | 0 0.000% | -2,312,786 (Position Closed) | Filing |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | VANGUARD GROUP INC | 2,312,786 7.090% | 104,675 (+4.74%) | Filing |
| 2023-02-09 11:16 am Sale | 2022-12-30 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | VANGUARD GROUP INC | 2,208,111 6.580% | -79,306 (-3.47%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | VANGUARD GROUP INC | 2,287,417 6.620% | 556,565 (+32.16%) | Filing |